Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.49, n°2 - April-June 2017 - The Affordable Care Act and drug abuse treatment
Auteur(s) :
PASSALACQUA, E. (Éditeur scientifique) ;
GUYDISH, J. (Éditeur scientifique) ;
SMITH, D. E. (Éditeur scientifique)
Paru le :
01/06/2017
Année
2017
Page(s) :
91-173
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Health reform and the substance use disorder treatment system: A time of change. Clark H.W., p. 91-94.
- Medicalizing the opioid epidemic in the US in the era of health care reform. Smith D.E., p. 95-101.
- Commercial health plan coverage of selected treatments for opioid use disorders from 2003 to 2014. Reif S., Creedon T.B., Horgan C.M., Stewart M.T., Garnick D.W., p. 102-110.
- Perceived impacts of the Affordable Care Act: Perspectives of buprenorphine prescribers. Knudsen H.K., Studts J.L., p. 111-121.
- The addiction benefits scorecard: A framework to promote health insurer accountability and support consumer engagement. Danovitch I., Kan D., p. 122-131.
- Integration of care in the implementation of the affordable care act: Changes in treatment services in a national sample of centers treating substance use disorders. Aletraris L., Roman P.M., Pruett J., p. 132-140.
- Insurance receipt and readiness for opportunities under the Affordable Care Act: A national survey of treatment providers for substance use disorders. Aletraris L., Edmond M.B., Roman P.M., p. 141-150.
- Massachusetts substance use disorder treatment organizations' perspectives on the Affordable Care Act: Changes in payment, services, and system design. Quinn A.E., Stewart M.T., Brolin M., Horgan C.M., Lane N.E., p. 151-159.
- Buprenorphine treatment and patient use of health services after the Affordable Care Act in an integrated health care system. Campbell C.I., Parthasarathy S., Young-Wolff K.C., Satre D.D., p. 160-168.
- A social work response to the Affordable Care Act: Prevention and early intervention. Corrigan M.J., Krase K., Reed J.C., p. 169-173.
- Health reform and the substance use disorder treatment system: A time of change. Clark H.W., p. 91-94.
- Medicalizing the opioid epidemic in the US in the era of health care reform. Smith D.E., p. 95-101.
- Commercial health plan coverage of selected treatments for opioid use disorders from 2003 to 2014. Reif S., Creedon T.B., Horgan C.M., Stewart M.T., Garnick D.W., p. 102-110.
- Perceived impacts of the Affordable Care Act: Perspectives of buprenorphine prescribers. Knudsen H.K., Studts J.L., p. 111-121.
- The addiction benefits scorecard: A framework to promote health insurer accountability and support consumer engagement. Danovitch I., Kan D., p. 122-131.
- Integration of care in the implementation of the affordable care act: Changes in treatment services in a national sample of centers treating substance use disorders. Aletraris L., Roman P.M., Pruett J., p. 132-140.
- Insurance receipt and readiness for opportunities under the Affordable Care Act: A national survey of treatment providers for substance use disorders. Aletraris L., Edmond M.B., Roman P.M., p. 141-150.
- Massachusetts substance use disorder treatment organizations' perspectives on the Affordable Care Act: Changes in payment, services, and system design. Quinn A.E., Stewart M.T., Brolin M., Horgan C.M., Lane N.E., p. 151-159.
- Buprenorphine treatment and patient use of health services after the Affordable Care Act in an integrated health care system. Campbell C.I., Parthasarathy S., Young-Wolff K.C., Satre D.D., p. 160-168.
- A social work response to the Affordable Care Act: Prevention and early intervention. Corrigan M.J., Krase K., Reed J.C., p. 169-173.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
D. E. SMITH
|
2017
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
The medicalization of the current opioid epidemic in the era of health care reform and parity, and its possible dismantling, poses many challenges. Between 2002 and 2013, drug overdose rates quadrupled. Parallel to an increase in prescription op[...]
L. ALETRARIS ;
P. M. ROMAN ;
J. PRUETT
|
2017
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
This study examined patterns of medicalization in substance use disorder (SUD) that are aligned with the goals of the Affordable Care Act (ACA). Using a nationally representative sample of SUD treatment programs, we examined changes in several t[...]
M. J. CORRIGAN ;
K. KRASE ;
J. C. REED
|
2017
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.49, n°2, April-June 2017) Article : Périodique
The Patient Protection and Affordable Care Act represents a reinvestment in primary care, with a focus on prevention of illness and remediation of the impacts of chronic diseases through a behavioral health framework. Licensed social work profes[...]